Boston Millennia Partners Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, Boston Millennia Partners has invested in 1 company.

Boston Millennia Partners’ most common sectors for investment are life science (31%) and healthcare services (16%). The Firm’s most common investment types include venture (62%) and growth capital (31%). In total, Boston Millennia Partners has invested in 9 US states and 2 different countries.

In the last 3 years, Boston Millennia Partners has exited 3 companies. The Firm’s most common exit type is trade sale (64%). Boston Millennia Partners’ largest (disclosed) exit occurred in 2004 when it sold ILEX Oncology for $1.0B.

Join Mergr to view Boston Millennia Partners’ full profile and discover more middle-market private equity firms just like it.

M&A Summary

  • M&A Total Activity24
    • M&A Buy Activity13
    • M&A Sell Activity11
  • Total Sectors Invested 7
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 13

Boston Millennia Partners

,
www.bostonmillenniapartners.com

Boston Millenia Partners is a growth capital investment firm focused rapidly growing business services and healthcare companies. The Firm generally looks to invest $3 to $10 million in companies at or near profitability with $3 to $30 million in sales. Boston Millenia's geographic preference is for opportunities in the Eastern half of the US. Boston Millenia Partners was formed in 1984 and has a single office in Boston.


Investment Criteria

Sectors of Interest: Business Services, Consumer Products, Healthcare Services, Information Technology, Internet Software and Services, Life Science, Media, Medical Products, Transportation

Target Transaction Types: Growth Capital, Stake Purchase, Venture

Geographic Preferences: East US, Midwest US, South US

Transaction Criteria Min Max
Target Revenue 3 30
Target EBITDA - -
Investment Size 3 10
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.8/yr) # 9 3 - - 1 - 13
Sell (0.8/yr) # 7 1 1 1 1 - 11
vol $1.6B $1.6B
  24

Most Recent M&A

Company Date Value Type
iQuartic, Inc. 2019-05-31 - Add-on Acquisition
Boston, Massachusetts · www.iquartic.com
Forefront Telecare, Inc. 2019-04-24 - Growth Capital
Hamilton, New Jersey · www.forefronttelecare.com
Bivarus, Inc. 2018-01-16 - Add-on Acquisition
Durham, North Carolina · www.bivarus.com
Odyssey Logistics & Technology Corp. 2017-08-30 - Secondary Buyout
Danbury, Connecticut · www.odysseylogistics.com
Cota, Inc. 2016-12-20 - Growth Capital
New York, New Jersey · www.cotahealthcare.com
BC Platforms 2016-11-24 - Growth Capital
Zurich, Switzerland · www.bcplatforms.com
Xconomy, Inc. 2016-08-01 - Add-on Acquisition
Boston, Massachusetts · www.xconomy.com
Bivarus, Inc. 2016-03-23 - Growth Capital
Durham, North Carolina · www.bivarus.com
Avhana Health, Inc. 2015-06-30 - Venture
Baltimore, Maryland · www.avhana.com
Collegium Pharmaceutical, Inc. 2015-05-07 - IPO
Stoughton, Massachusetts · www.collegiumpharma.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science - - 4 (31%) -
Healthcare Services 2 (33%) - 2 (15%) -
Information Technology 2 (33%) - 2 (15%) -
Internet Software and Services 1 (17%) - 2 (15%) -
Business Services - - 1 (8%) -
Medical Products 1 (17%) - 1 (8%) -
Transportation - - 1 (8%) -
Total 6 - 13 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 5 (83%) - 12 (92%) -
  Massachusetts 1 (17%) - 3 (23%) -
  New Jersey 2 (33%) - 2 (15%) -
  Maryland 1 (17%) - 1 (8%) -
  Georgia 1 (17%) - 1 (8%) -
  Washington - - 1 (8%) -
  Texas - - 1 (8%) -
  North Carolina - - 1 (8%) -
  New Hampshire - - 1 (8%) -
  Connecticut - - 1 (8%) -
Switzerland 1 (17%) - 1 (8%) -
Total 6 - 13 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 2 (33%) - 8 (62%) -
Growth Capital 3 (50%) - 4 (31%) -
Stake Purchase 1 (17%) - 1 (8%) -
Total 6 - 13 -

Exits by Deal Type

Type Total # Value
Trade Sale 4 (36%) 578M (37%)
Trade Sale - Public Company 3 (27%) 1.0B (63%)
IPO 2 (18%) -
Merger 1 (9%) -
Secondary Sale 1 (9%) -
Total 11 $1.6B

Deal Values

sell # Total
> $1B 1 $1.0B
$100M to $1B 2 $578M
TOTAL $1.6B
Largest ILEX Oncology, Inc.
$1.0B (2004-12-21)

M&A Connections

Deals %
Exited to
PE Firm(s)
11%
1 11%
Strategic(s)
89%
8 89%